HoLEP — What It Is, How It Works, What to Expect

Holmium Laser Enucleation of the Prostate is a single operation that does definitively what every other benign prostatic hyperplasia (BPH) procedure does partially. This page explains how it works, who it’s for, and what to expect from the experience.

What HoLEP is

HoLEP stands for holmium laser enucleation of the prostate. It is a transurethral operation — performed through the urethra, with no skin incisions — that removes the obstructing inner portion of an enlarged prostate using a holmium:YAG laser, then morcellates (the freed tissue is broken into tiny fragments and suctioned out through the scope) and extracts the removed tissue through the same access channel.

The closest analogy is hollowing out an orange. The prostate has an inner adenoma (the part that grows with age and causes obstruction) and an outer surgical capsule. HoLEP develops the plane between these two layers and enucleates (the prostate's inner core is removed whole, leaving the outer shell intact) the adenoma completely — leaving the capsule intact and the urethral channel newly open. Every gram of obstructing tissue is removed, sent to pathology, and unavailable to grow back.

This is a fundamentally different operation from minimally invasive procedures that either compress tissue (UroLift), shrink it (Rezum, prostatic artery embolization), or vaporize it (GreenLight, some Aquablation cases). HoLEP removes tissue completely and permanently. That single mechanical difference is the reason its durability is unmatched.

How it works in the operating room

The patient is asleep under general anesthesia, or numb from the waist down under spinal anesthesia — both are common; the choice depends on patient-specific factors. The operation typically takes one to two hours, depending on prostate size. A few specifics worth knowing:

A specialized resectoscope (a slim instrument passed through the urethra that the surgeon works through) is inserted through the urethra. Nothing is cut on the outside of the body.
The holmium laser fiber is used to develop the plane between the prostate adenoma and the capsule, then to release the adenoma from its attachments.
The freed lobes of adenoma are pushed into the bladder, where a motorized morcellator breaks them into small fragments that are extracted through the resectoscope.
The fragments go to a pathologist. About 10% of HoLEP specimens contain incidentally identified prostate cancer that would not have been detected by other BPH procedures.
A urinary catheter (a thin, flexible tube that drains urine from the bladder) is placed at the end of the procedure to drain urine and allow the surgical area to heal. The catheter typically stays in place for less than 24 hours; in many patients, it can be removed the same day.

In a hospital like UR Medicine, an experienced HoLEP surgeon can do same-day discharge for the majority of patients — go home the day of surgery, voiding on your own. Dr. Quarrier has published on the same-day discharge protocol; for a sizable fraction of patients, an overnight stay is unnecessary.

Watch: BPH 101 with Dr. Quarrier

This is Dr. Quarrier’s full BPH 101 talk — a thorough walk through diagnosis and the range of treatment options. If you’d rather read, the rest of this page covers the essentials.

Who HoLEP is for

HoLEP works for essentially the full range of patients with surgical BPH:

Any prostate size. HoLEP is the only BPH procedure with randomized trial evidence supporting use in prostates above 100 grams, and routine use extends to 300 grams and beyond. There is no upper size limit imposed by the procedure itself.
Men with severe symptoms for whom medication has not worked, has stopped working, or causes intolerable side effects.
Men in urinary retention (being unable to empty the bladder on your own) who depend on a catheter, including men who have been told they are not surgical candidates elsewhere because of prostate size or comorbidity (other ongoing medical conditions).
Older men — published outcomes are excellent in men over 80, and the most-cited recent series demonstrates safety and effectiveness even in men over 85.
Men with comorbidities including significant cardiac, pulmonary, or renal disease. Because HoLEP is hemostatic — it cauterizes as it cuts — the bleeding-related risk profile is meaningfully lower than alternatives like transurethral resection of the prostate (TURP).
Men on blood thinners — particularly antiplatelet (a type of blood thinner, such as aspirin or clopidogrel) agents and direct oral anticoagulants (blood-thinning medication). HoLEP has a favorable bleeding profile in anticoagulated patients (in the GRAND nationwide inpatient registry, HoLEP/thulium laser enucleation of the prostate (ThuLEP) transfusion rates were roughly one-third of TURP’s), and the procedure can often be performed without interrupting these medications. For patients on warfarin or on dual antiplatelet therapy for cardiac stents, this is a major practical advantage.
Men who want one-and-done. HoLEP retreatment rates are essentially zero at 5–7 years in long-term randomized cohorts.
Men who have failed previous BPH procedures. Patients whose UroLift, Rezum, GreenLight photoselective vaporization (PVP), or even prior TURP did not deliver durable relief can be HoLEP candidates.

Who HoLEP is generally not for

There are a few situations where HoLEP is not the right operation:

Men with active prostate cancer requiring oncologic treatment first (HoLEP can be discussed afterward).
Men with a known urethral stricture (a scar-tissue narrowing of the urethra) that would prevent passage of the resectoscope.
Men with a neurologic bladder where the obstruction is not the actual problem (HoLEP fixes the prostate; it doesn’t fix bladder muscle dysfunction).
Men with very small prostates and primarily irritative symptoms — for whom alpha-blockers (a common prostate medication that relaxes the bladder neck, e.g. tamsulosin) or behavioral modification may be more appropriate.

A urology consultation determines candidacy. Most men who think they’re not candidates for definitive surgery are — particularly older men, men in retention, and men with very large glands.

What to expect — before surgery

In the weeks leading up to HoLEP, you may have:

A consultation visit to confirm candidacy, review imaging, and discuss alternatives.
Pre-operative imaging — typically a transrectal ultrasound or MRI to confirm prostate volume and rule out other findings.
Pre-operative laboratory testing — urinalysis (to confirm absence of active infection), basic metabolic panel, complete blood count, and a coagulation panel for patients on blood thinners.
Anesthesia evaluation, particularly for patients with significant cardiac or pulmonary history.
Specific instructions about medications. Most men on alpha-blockers (tamsulosin, alfuzosin) can continue them up to and after surgery. Men on 5-alpha-reductase inhibitors (finasteride, dutasteride) are usually instructed to continue. Blood-thinner management is individualized — your surgeon will direct.
Standard pre-operative instructions: nothing to eat or drink after midnight the night before; arrive a couple of hours early on the day of surgery.

There is no bowel preparation. There is no shaving required beforehand. You will not need to stop your usual blood pressure medications.

What to expect — the day of surgery

Day-of structure typical for HoLEP at a center like UR Medicine:

Arrival and check-in — typically 90 minutes before scheduled surgery time. You meet your anesthesia team and surgical team, sign consents, and have an IV placed.
Anesthesia induction — general or spinal, depending on plan.
Surgery itself — usually one to two hours, depending on prostate size. The operating-room team includes the surgeon, an anesthesiologist, an OR nurse, and a surgical technician.
Recovery room — typically one to two hours waking up from anesthesia. A urinary catheter is in place; you may notice some pink-tinged urine in the drainage bag, which is normal.
Floor or short-stay observation — depending on the discharge plan. For same-day discharge, you’ll have a brief observation period, demonstration that you can stand and walk, and a discharge education session before going home with the catheter in place.
Catheter management at home — the catheter is drained into a leg bag during the day and a larger overnight bag at night. You’ll receive specific instructions on cleaning, drainage, and what to watch for.

Discharge is the same day for the majority of HoLEP patients. Overnight observation is reserved for patients with specific medical indications (severe cardiac history, intraoperative findings requiring monitoring), or for patients who specifically prefer an overnight stay.

What to expect — the first week

Recovery follows a generally predictable arc, but every patient varies. Common features of the first week:

Catheter removal at home — typically 24–48 hours after surgery. Most men remove the catheter themselves at home, following written and hands-on instructions given before discharge; a routine return visit just for catheter removal is not needed. If you cannot urinate after removing it, call the office — the catheter can be replaced briefly and removed again a few days later.
Strong stream, sometimes spraying — the urethral channel is now open in a way it hasn’t been in years. The stream is noticeably stronger than before. Some men describe spraying or a slightly altered direction; this generally improves over the first few weeks.
Blood in the urine — small amounts of blood and small clots are normal in the first week. Drinking 2–3 liters of water per day, spread through the day, helps flush this through. Strenuous activity or constipation can trigger temporary increases in bleeding; both are worth avoiding.
Urinary urgency and frequency — the bladder is healing and the new outflow geometry takes adjustment. Urgency in the first week or two is common and usually subsides.
Some incontinence — temporary stress-related leakage is common in the first weeks, particularly in older men or those with very large prostates. Most leakage resolves within 4–12 weeks.
Pelvic discomfort — mild burning at the end of urination, occasional perineal aching. Acetaminophen and adequate hydration usually suffice.

You should not need narcotic pain medication for more than a few days, if at all.

What to expect — weeks two through twelve

Most men feel substantially better within two weeks and “substantially healed” by six to eight weeks. Some specifics:

Stream and urgency improve progressively. By 4–6 weeks, the stream is typically the strongest it has been in many years, and urgency has largely subsided.
Nocturia (getting up at night) improves over the same window. Most men report fewer nighttime trips by week 6 than they had been having before surgery.
Ejaculation becomes “dry” (retrograde ejaculation) — it helps to be clear about what this does and does not mean, because sexual function is more than ejaculation. Your erections are not affected — the nerves that control them are not in the surgical field — and your orgasm feels the same; most men describe the sensation as unchanged, and some report it more intense. The single change is that at climax the semen travels backward into the bladder instead of out, so little or nothing comes out in the moment. This is harmless and not painful — the fluid simply leaves the next time you urinate. The change is usually permanent and does reduce fertility, so men who may want to father children should raise that before surgery. For the great majority of men, erections, orgasm, and sexual satisfaction are unchanged.
Erectile function — the underlying nerves controlling erection are not in the surgical field. Erectile function is preserved in most men. The published long-term head-to-head data for HoLEP vs. other procedures show HoLEP performs as well as or better than alternatives on long-term erectile preservation.
Activity restrictions — no heavy lifting (over ~15 lb) and no intense exercise for 4–6 weeks. Avoid bicycling, lawn mowing, and riding mowers or tractors for 6 weeks — the pelvic vibration can trigger bleeding. Walking and stretching are encouraged. Most men can return to a desk job within 1–2 weeks; physical jobs typically require 4–6 weeks.
Resumption of sex — typically 4-6 weeks, with surgeon clearance. Some men resume sooner.
Driving — once you are off narcotics and feeling fully alert; for most men, within a few days.

What to expect — beyond three months

Most of the surgical recovery is complete by 12 weeks. Long-term:

Symptom relief is durable. Long-term cohort data show HoLEP retreatment rates near zero at 5 and 7 years.
Prostate-specific antigen (PSA) drops substantially after HoLEP — typically by 80% or more — because most of the prostate volume has been removed. This drop is a useful baseline for future prostate cancer screening.
Stress incontinence in a small minority of men (roughly 1% or less in long-term reporting) can persist beyond 3 months. Dr. Quarrier has published specifically on predictors of post-HoLEP continence outcomes; the data inform how candidates are counseled and how the operation is performed.
Return to normal life. Many patients describe sleeping through the night for the first time in years, finishing long drives without bathroom stops, and resuming activities they had quietly stopped because of urinary urgency. The single most common patient comment in long-term follow-up: “I should have done this sooner.”

What HoLEP doesn’t fix

Honest framing: there are urinary problems that HoLEP does not solve.

Overactive bladder (urgency, frequency from bladder muscle hyperactivity, independent of obstruction) is a separate condition. HoLEP may improve it indirectly by removing obstruction, but it doesn’t treat it directly.
Stress urinary incontinence unrelated to prostate surgery is not fixed by HoLEP.
Erectile dysfunction caused by other conditions (vascular, neurological, hormonal) is not improved by HoLEP — though longstanding lower urinary tract symptoms (LUTS) often co-occur with ED, and treating the LUTS sometimes appears to improve the ED.
Prostate cancer. HoLEP is a treatment for benign prostatic enlargement. If cancer is identified incidentally on the HoLEP specimen, the management plan is discussed afterward.

Any honest BPH conversation includes what the operation can and cannot do.

Common questions

Will I be able to control my urine? The vast majority of men have full urinary control by 3 months, often much sooner. Temporary stress-related leakage in the first weeks is common.

Will I be impotent? HoLEP does not cause erectile dysfunction in most men. Erectile function is preserved in the published long-term data.

Will I have to do it again? Almost certainly not. HoLEP retreatment rates are near zero at 5 and 7 years.

Will I still ejaculate? You will still have erections and orgasms, and the sensation is normal or near-normal. The one change is that the fluid travels backward into the bladder instead of out, so the orgasm is “dry” — little or nothing comes out in the moment, and it passes harmlessly the next time you urinate. This is called retrograde ejaculation. It is usually permanent and reduces fertility, but it does not affect your ability to get an erection, to reach orgasm, or to enjoy sex.

How big is too big for HoLEP? There is no upper limit imposed by the procedure. HoLEP routinely handles prostates from 30 grams to over 300 grams.

Can I do HoLEP if I’m on blood thinners? In most cases, yes. HoLEP is the safest enucleation procedure for patients on anticoagulation. Specific medication management is individualized.

What if I’ve already had UroLift / Rezum / GreenLight and it failed? HoLEP is an appropriate option after failed minimally invasive procedures. Many HoLEP patients arrive after one or more prior procedures.

What about cancer detection? Tissue removed during HoLEP goes to pathology. About 10% of HoLEP specimens contain incidentally identified prostate cancer.

What to do next

To discuss whether HoLEP is the right procedure for your specific situation, call UR Medicine Urology at (585) 275-2838 to schedule a consultation with Dr. Quarrier.

Dr. Quarrier operates at both Strong Memorial Hospital and Highland Hospital in Rochester, NY, and sees patients at the UR Medicine Urology clinic on 158 Sawgrass Drive.